
Cancer therapy with a combination of oncolytic bacteria and virus to enhance targeted cell killing and anti-tumor immune responses
-
Award Number: R21CA249517
-
ORGANIZATION: NATIONAL CANCER INSTITUTE
-
OPDIV: NIH
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)